ADVANCED MTAP-NULL SOLID TUMORS

Clinical trials for ADVANCED MTAP-NULL SOLID TUMORS explained in plain language.

Never miss a new study

Get alerted when new ADVANCED MTAP-NULL SOLID TUMORS trials appear

Sign up with your email to follow new studies for ADVANCED MTAP-NULL SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New targeted drug trial offers hope for Tough-to-Treat cancers

Disease control Ongoing

This study is testing a new oral drug, AMG 193, for people with advanced solid tumors that have lost a specific gene called MTAP. The main goals are to find a safe dose, see how the body processes the drug, and check if it helps shrink tumors, both by itself and when given with a…

Matched conditions: ADVANCED MTAP-NULL SOLID TUMORS

Phase: PHASE1, PHASE2 • Sponsor: Amgen • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

ADVANCED MTAP-NULL SOLID TUMORS

Get alerted when new ADVANCED MTAP-NULL SOLID TUMORS trials appear

New targeted drug trial offers hope for Tough-to-Treat cancers